Insmed Announces Publication of Phase 2 Study of ARIKAYCE in Treatment-Refractory Nontuberculous Mycobacterial Lung Disease
October 18, 2016 08:00 ET
|
Insmed Incorporated
Data in American Journal of Respiratory and Critical Care Medicine demonstrate ARIKAYCE’s potential to achieve early and sustained negative sputum cultures BRIDGEWATER, N.J., Oct. 18, 2016 ...
Insmed Announces Worldwide License Agreement with AstraZeneca for Oral DPP1 Inhibitor
October 05, 2016 06:55 ET
|
Insmed Incorporated
BRIDGEWATER, N.J., Oct. 05, 2016 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today...
Insmed Appoints Roger Adsett as Chief Commercial Officer
September 27, 2016 08:00 ET
|
Insmed Incorporated
BRIDGEWATER, N.J., Sept. 27, 2016 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today...
Insmed to Participate at September Investor Conferences
September 08, 2016 08:00 ET
|
Insmed Incorporated
BRIDGEWATER, N.J., Sept. 08, 2016 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today...
Insmed Announces Upcoming Presentations at European Respiratory Society 2016 International Congress
August 31, 2016 08:00 ET
|
Insmed Incorporated
BRIDGEWATER, N.J., Aug. 31, 2016 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today reported...
Insmed Reports Second Quarter 2016 Financial Results
August 04, 2016 08:02 ET
|
Insmed Incorporated
BRIDGEWATER, N.J., Aug. 04, 2016 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today reported...
Insmed Announces Withdrawal of Marketing Authorization Application for ARIKAYCE™ in Europe
June 08, 2016 16:30 ET
|
Insmed Incorporated
BRIDGEWATER, N.J., June 08, 2016 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today...
Insmed to Present at the Bank of America Global Healthcare Conference
May 09, 2016 08:00 ET
|
Insmed, Inc.
BRIDGEWATER, N.J., May 09, 2016 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today reported...
Insmed Reports First Quarter 2016 Financial Results
May 05, 2016 08:03 ET
|
Insmed, Inc.
BRIDGEWATER, N.J., May 05, 2016 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today reported...
Insmed Announces Upcoming Presentations at the American Thoracic Society 2016 International Meeting
May 03, 2016 08:00 ET
|
Insmed, Inc.
BRIDGEWATER, N.J., May 03, 2016 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today reported...